WHITEHOUSE STATION, N.J.--Merck, known as MSD outside the United States and Canada, today said a jury found in its favor in the Glynn v. Merck case in the U.S. District Court for the District of New ...

Women who have ever used alendronate sodium may be at an increased risk of incident atrial fibrillation, according to recent data published in the Archives of Internal Medicine. Researchers from ...

The bisphosphonate alendronate sodium increases bone mineral density in patients with immunobullous diseases and glucocorticoid-induced osteoporosis, according to study results. The double blind, ...

WHITEHOUSE STATION, N.J., Oct. 4, 2010 - Merck & Co., Inc. today said it will appeal a decision by the U.S. District Court for the Southern District of New York that reduced the jury verdict from $8 ...

In re Fosamax (Alendronate Sodium), No. 11-5304, 08-08; U.S. District Court (DNJ); opinion by Pisano, U.S.D.J.; filed June 27, 2013. DDS No. 36-7-xxxx [17 pp.] Fosamax (Alendronate Sodium) is approved ...

WASHINGTON, Feb. 7 (UPI) -- The U.S. Food and Drug Administration has approved the first generic versions of the osteoporosis drug Fosamax (alendronate sodium tablets). Teva Pharmaceuticals USA of ...

NORTH WALES, Pa. Teva has announced the introduction and availability of alendronate sodium tablets. This is the generic version of the osteoporosis drug Fosamax by Merck. The drug will be available ...

BINOSTO (alendronate sodium) 70mg effervescent tablet for oral solution by Mission Pharmacal EffRx announced that the FDA has approved Binosto (alendronate sodium) Effervescent Tablets for the ...

Is there any food or drink I need to avoid. Alendronate Osteoporosis Prevention Fosamax d 70mg Group. More than one-third of patients in this study reported Fosamax d 70mg however, other multivalent ...

TRENTON, N.J. — At least three generic versions of the popular osteoporosis treatment Fosamax are headed for pharmacy shelves with the expiration of the drug’s main patent Wednesday, bringing patients ...

(Reuters Health) - Media reports raising safety concerns about osteoporosis drugs known as bisphosphonates may have contributed to a sharp drop in their use - even though U.S. doctors and drug ...